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Abstract
Background: Necrotizing Enterocolitis (NEC) is a major cause of morbidity and mortality in the Neonatal
Intensive Care Unit (NICU), yet the global incidence of NEC has not been systematically evaluated. We
conducted a systematic review and meta-analysis of cohort studies reporting the incidence of NEC in infants
with Very Low Birth Weight (VLBW).
Methods: The databases searched included PubMed, MEDLINE, the Cochrane Library, EMBASE and grey
literature. Eligible studies were cohort or population-based studies of newborns including registry data
reporting incidence of NEC. Incidence were pooled using Random Effect Models (REM), in the presence of
substantial heterogeneity. Additional, bias adjusted Quality Effect Models (QEM) were used to get sensitivity
estimates. Subgroup analysis and meta-regression were used to explore the sources of heterogeneity. Funnel
plots as appropriate for ratio measures were used to assess publication bias.
Results: A systematic and comprehensive search of databases identified 27 cohort studies reporting the
incidence of NEC. The number of neonate included in these studies was 574,692. Of this 39,965 developed
NEC. There were substantial heterogeneity between studies (I2 = 100%). The pooled estimate of NEC based on
REM was 7.0% (95% CI: 6.0–8.0%). QEM based estimate (6.0%; 95% CI: 4.0–9.0%) were also similar. Funnel plots
showed no evidence of publication bias. Although, NEC estimates are similar across various regions, some
variation between high and low income countries were noted. Meta regression findings showed a statistically
significant increase of NEC over time, quantified by the publication year.
Conclusion: Seven out of 100 of all VLBW infants in NICU are likely to develop NEC. However, there were
considerable heterogeneity between studies. High quality studies assessing incidence of NEC along with
associated risk factors are warranted.
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Background
Last three decades have witnessed great improvements
in the neonatal intensive care, in particular, with the
introduction of surfactant therapy and the subsequent
improvement in the care of respiratory distress syn-
drome (RDS) that reduced the mortality among pre-
term newborns [1]. With better survival of premature
babies, Necrotizing Enterocolitis (NEC) became more
common and its burden became more prominent [2].
Multiple population-based studies, some based on
large cohort studies, have reported the incidence of
NEC to vary from 2 to 13% in preterm and Very Low
Birth Weight (VLBW) infants [2–6]. The variation in
the incidence were attributed to differences in the
risk factor profiles as well as differing population at
risk, detection rate and inclusion and exclusion cri-
teria. There is no pooled estimate of the incidence of
NEC worldwide. Furthermore, there is no incidence
data from some regions such as North Africa, the
Middle East or the Arab Gulf region, apart from a
single study from the UAE [7].
With the continuing improvement in survival of pre-
term newborns, the modifiable risk factors of NEC need
to be studies and made use of in developing appropriate
interventions to reduce the incidence and impact of
NEC. In this context, clinicians and researchers have
attempted to identify the factors associated with risk and
prognosis of NEC. It was reported as early as the 1980’s,
that there exist an association between rapid advance-
ment of feeding and the onset of NEC [8]. Subsequent
reports showed preterm birth [9, 10], small birth weight
[9–11] and race [11] were also to be important risk fac-
tors. Contemporary reports confirm these initial reports
and expand the list to include a few more. More recent
studies have shown that preterm birth [3, 12]. low birth
weight [2, 12], rapid advancement of feeding, race and
ethnicity, use of glucocorticosteriods [2], maternal infec-
tion [13], indomethacin therapy [14], congenital pneu-
monia [14], meconium aspiration [15], asphyxia [15],
blood transfusion [15] and hypotension within the first
week of life [16] are also potential contributing factors.
This study aims to systematically review the incidence
reported from different parts of the world to synthesize
a global incidence of confirmed NEC in VLBW infants.
The study also aims to explore the regional variability as
well as other potential factors that can explain variability
in the incidence.
Methods
The recommendations from the Preferred Reporting
Items for Systematic Review and Meta-Analysis (PRIS
MA) served as the guide in collating and reporting this
review [17].
Eligibility criteria
Eligible studies included cohort or population-based
studies of newborns including registry data. Both pro-
spective and retrospective studies were included. Studies
reporting the number, frequency or incidence of con-
firmed NEC in preterm infants or VLBW infants along
with appropriate denominator were included. Studies
that reported data on subgroups of infants with specific
exposures such as congenital heart disease, perinatal in-
fections, preterm rupture of membrane, or sepsis were
excluded when the incidence could not be extracted.
Studies with unclear case definitions of NEC were also
excluded. Randomized controlled trials had strict selec-
tion criteria therefore including them would have caused
selection bias and reduced the external validity of our
pooled estimate. Hence, experimental studies that were
assessing the effect of an intervention on a selected
group of neonates were excluded. Case series where
there were no denominator data to compute the inci-
dence were also excluded.
Incidence is used as opposed to prevalence because of
the natural history of NEC and its short duration of dis-
ease. It is envisaged that findings form this study would
provide clinically important baseline data as the starting
point for studies that aim to reduce the incidence of NEC.
Population and outcome
The VLBW infants formed the population of this study
and the outcome of was the incidence of NEC stage II
or above according to Bells criteria.
Search data bases
The database search was started in September 2018 and
last updated in December 2019. The databases searched
were PUBMED, MEDLINE (Ovid), EMBASE, the
Cochrane Library. Additional databases searched in-
cluded: African Index Medicus Database, Latin America
and Caribbean Center of Health Science International,
Open Grey, IndMED, KoreaMED, Virtual Health Li-
brary, National Library of Australia and Social Care On-
line.. Further manual search included looking for
relevant studies in the reference lists of the included
papers.
Search strategy
The search strategy was developed by the authors to in-
clude a comprehensive database search using broader
search terms such as: “Enterocolitis, Necrotizing”, “Epi-
demiology”, “Incidence”, “Cohort Studies”, and “popula-
tion-Based studies”, “cohort studies”, “epidemiological
data”, “prematurity”, “Very low birth weight”, “clinical
study”, “cohort analysis”, and “‘human”. Additional
MeSH (Medical Subject Heading) term based search
complemented the above search. When appropriate
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using the above terms with a combination of ‘and’ and
‘or’ in accordance with search engine specifications were
carried out. The search string used for PUBMED is given
in Supplementary file S1 as an illustration.
Study selection
Two review authors (AA and NI) independently assessed
the titles and abstracts of all citations retrieved by the
search for relevance against the inclusion criteria. Then
the full-text versions of studies considered potentially
eligible were retrieved. The same two authors independ-
ently assessed the full papers for eligibility, with dis-
agreements resolved through input of the third author.
The duplicate records and those not eligible were elimi-
nated and a PRISMA flow chart was created to depict
the study selection process.
Data extraction
Data form the eligible studies were extracted and col-
lated on to data tables. Name of the authors, year of
publication, data on the time period covered by the
study, location of the study, inclusion and exclusion cri-
teria of the study (Table 1), the reported population at
risk and whether it was VLBW infants or preterm in-
fants, case definition, incidence or number on NEC cases
and size of population at risk (Table 2) were collected.
The data extraction process was performed by AA and
checked by NI. Any discrepancies is resolved by
discussion.
Risk of Bias assessment
All the included studies were assessed for internal and
external validity using the criteria put forward by Hoy
et al. that were specific for prevalence and incidence
studies (Fig. 1). This tool was developed based on key
domains they identified to be important in assessing the
risk of bias in incidence and prevalence studies. The tool
was subsequently validated and found to have good val-
idity [30].
Data synthesis
Pooling the incidence estimates was done after arcsine
transformations of the data as it has been shown to
stabilize variance and reduce bias [31]. Heterogeneity
was assessed using the Cochrane Q test and Higgin’s I2
value. Smaller p values and I2 > 50% were indicative of
significant heterogeneity [32, 33]. As Cochrane guide-
lines suggest use of Random Effect Models (REM) when
significant heterogeneity is encountered [34] we
employed REM models estimates to arrive at the main
conclusion. Further, bias adjusted Quality Effect Models
(QEM) [35] were used to obtain sensitivity estimates to
check the robustness of the REM estimates. Quality
scores obtained using Hoy’s criteria were used in fitting
the QEM.
Forest plots were used to display the incidence of NEC
with corresponding 95% confidence intervals. We used
Hunter plots to assess the publication bias as Hunter
et al. have shown the classical funnel plot to be in-
appropriate for proportion studies such as prevalence or
incidence [36].
A-priori planned meta-regression was performed to
evaluate if the publication year has any impact on the
variability of the incidence and as a possible cause of
heterogeneity. This was also thought to be important
to understand if the long term trend in incidence of
NEC to see if they are on a rise or decline. Further
subgroup analysis by region based on income category
of the countries provided by World Bank and popula-
tion at risk (VLBW or extremely premature) was also
carried out [37]. This sub-group analysis was not an
a-priori decision but an attempt to explain the vari-
ability in NEC due to substantial heterogeneity.
Groups consisted of high income countries (HIC) and
low middle-income countries (LMIC).
The meta analyses were carried out using MetaXL [31]
and the subgroup analysis and meta regression were car-
ried out using Comprehensive Meta-Analysis (CMA-V3)
software [38].
Results
Study characteristics
The total number of publications identified for screening
was 1694. The process of selection of eligible studies are
depicted as a PRISMA flow chart (Fig. 2). A total of 27
studies were found to fulfill the eligibility criteria and in-
cluded in the review (Table 1). The number of neonate
included in these studies was 574,692. Of these, 39,965
neonates developed confirmed NEC (Table 2). The stud-
ies covered a broader geographical areas globally. Some
regions had multiple studies other areas had none. A
total of eight studies were reported from the United
States covering a number of states including: California,
Texas, Atlanta, Connecticut, and New York [3, 6, 9, 18,
19, 39–41]. Multiple studies were also reported from the
Europe including Poland, Romania, Finland, Belgium,
Sweden and Switzerland [12, 13, 23, 39, 42, 43]. Also,
four studies were done in China, Korea, Singapore and
Malaysia [14, 16, 44, 45]. Three studies from Australia
[4, 21, 46], one from the Middle East [7] and one from
India [24].
The publication year of the studies ranged from 1988
to 2019, but the majority were carried out after 2000.
Some of the studies focused on evaluating a certain ex-
posure [7, 9, 21, 43], however, the data presented in
these papers were not limited to the exposure groups
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Table 1 Characteristics of the included studies
Author/year data base studied Inclusion criteria Exclusion criteria Population at risk
reported
NEC case definition Comment on
VLBW
Incidence
(cumulative)
Stoll et al.
2010 [18]
NICHD VLBW infants born
in NRN centers GA
22–28 wks.
Congenital
anomalies
preterm infants
among a VLBW
pool
clinically exclusively
VLBW infants
11%
Llanos et al.
2002 [3]
Finger Lakes
regional center
all live births in an
area of 6 counties.
Data obtained
from a state-wide
registry.
not clear all newborns in
the regional
center were
accounted for
but specific
report on NEC
stage II and
above among
the VLBW infants
is extracted
NEC stage II and
above
population
based study
but reported
specific
parameters on
VLBW
3.29%
Luig et al.
2005 [4]
New South Wales
– state-wide data
base. NICUS Neo-
natal Intensive
Care Unit Study
population based
study - all preterm
infant s between
24 and 28 wks.
not clear all preterm
infants 24–28
weeks of
gestation
Clinical definition as
confirmed NEC on a
set of criteria similar
to Bell’s criteria
the mean birth
weight and SD
of the three
epochs were
959 (240), 946
(204), and 935
(240)
7.67%
Holman
et al. 2006
[19]
data from
discharge registry
(the kid’s
Inpatient
Database)
compiled data
from 27 states,
2700 hospitals
accounting for
10%
uncomplicated
births from these
hospitals
the data is a
comprehensive
cohort of 10% of
all live births in
the specified
hospitals.
NE after 1 month of
age
VLBW infants ICD 9 -CM code NEC
777.5
Specific report
NEC and VLBW
infants is
presented
exclusively
VLBW infants
4.34%
Youn 2015
[16]
Korean Neonatal
Network.
Admissions into
55 participating
neonatal intensive
care unites
all live births or
admissions within
28 days. VLBW
infants. Data
collected
52 were diagnosed
with NEC II and
Spontaneous bowel
perforation and were
excluded
VLBW infants bell’s stage II and
above
exclusively
VLBW infants
6.41%
Qian et al.
2017
95 major referral
centers in 29
provinces.
Representative of
NICU care in the
areas
all LBW infants
were included.
not specified the study reports
specific
parameters of
VLBW infants
bell’s stage II and
above
reports on
VLBW infants
are extracted
from the
publications
2.53%
Ahle et al.
2013 [12]
Swedish National
Board of Health
and Welfare, the
National Patient
Register, the
Swedish Medical
Birth Register and
the National
Cause of Death
Register
all newborns
between 1987 and
2009
incomplete identity
number
VLBW infants ICD 9 or ICD 10
code 777F or P77
reported all
birth weights.
Exact
parameters of
each weights
group are
available too
2.68%
Wojkowska-
Mach et al.
2014
Polish Neonatal
Surveillance
Network
all VLBW infants
born in PNSS
missing records VLBW infants NEC defined
according to
Gastmeier’s (clinical)
exclusively
VLBW
8.68%
Boo et al.
2012 [14]
Malaysian
National Neonatal
Registry includes
NICUs in Malaysia
All VLBW infants in
the MNNR.
excluded infants less
than 501 g
VLBW infants bell’s stage II and
above
exclusively
VLBW infants
6.20%
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Table 1 Characteristics of the included studies (Continued)
Author/year data base studied Inclusion criteria Exclusion criteria Population at risk
reported
NEC case definition Comment on
VLBW
Incidence
(cumulative)
Wong et al.
2013
Population based
study: New South
Wales and
Australian Capital
Territory NICUs
included in the
NICUS
Low birth weight
infants
congenital
malformation,
syndromes with
neurodevelopmental
disorders, death in
the labor room
low birth weights
infants
Bell’s staging criteria the population
was of low
birth weights
(mean birth
weight in two
groups was
895 and 917 g.
7.81%
Fanaroff
2003 [20]
NICHD.
Retrospective
data analysis was
performed to
compare three
epochs.
Registry data not specified VLBW infants not clear VLBW infants 6.23%
Chedid
et al. 2008
Single large
Neonatal tertiary
referral center
all admission to a
single tertiary
center in Alain
between 2004 and
2006
life threatening
malformation, died in
labor room, less than
500 g
VLBW infants
(exclude less
than 500 g
not clear,
pneumatosis
intestinal or
perforation was used
a confirmation
all are VLBW 5.78%
Agrawel
et al. 2015
data from single
largest tertiary
hospital in
Singapore.
Viability threshold
less than 25 wks.
Gestation
Neonates from
High risk VLBW
data base with
GA < 29 wks.
still birth and
miscarriage, less than
23 weeks of
gestation
VLBW and pre-
term
bell’s stage II and
above
exclusively
VLBW infants
6.98%
Patole et al.
2016 [21]
single center
experience.
Comprehensive
retrospective
cohort comparing
a before and after
intervention
all neonates less
than 34 weeks of
gestation within a
2-year period be-
fore and after
intervention
neonates involved in
a clinical trial for the
same purpose
the study
reported all
neonates less
than 34 wks. But
data on < 28
weeks and epoch
1 were extracted
bell’s stage II and
above
the birth
weight of the
preterm babies
was not
specifically
reported
6.40%
Verstreate
et al. 2016
Retrospective
cohort study from
a single e center
using a local audit
data base
All neonates in
the hospital
system
neonates with
culture samples that
had probably
contamination
data on VLBW
was extracted
only
clinical definition the data
extracted
represents
exclusively
VLBW infants
16.23%
Harkin et al.
2017
Finish Medical
Birth Register
(preterm < 32
wks.) 22–31. all
VLGA 4143
all born less than
32 weeks of
gestation
congenital
malformations sever
chromosomal defects
or death before 7
days od life
less than 28
weeks of
gestation
clinical criteria 50% less than
1000 g in the
entire
populations.
But weight of
the < 28 weeks
of gestation
was not
specified
6.58%
Andersen
et al. 2018
birth cohort of
the California
Office Statewide
Health and
Development
(OSHPD)
all live births with
GA 22–36
chromosomal
abnormalities
GA less than 28
weeks
ICD-9 no clear
specification of
the birth
weight of the
preterm
subpopulation
9.10%
Suciu et al.
2017 [22]
From three
Romanian
hospitals (tertiary
centers) data from
two different
periods 2007–
2010 and 2011–
2014
all preterm babies
less than 28 weeks
of gestation
chromosomal
abnormalities and
birth defects or
missing data
preterm babies
less than 28
weeks of
gestation
bell’s stage II and
above
the mean birth
and SD of the
two epochs
were 809 +/−
211 and 958
+/− 149
17.08%
Patel et al.
2016
Prospective
0bservational
VLBW infants not specified VLBW infants bell’s stage II and
above. Cumulative
exclusively
VLBW infants
7.34%
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Table 1 Characteristics of the included studies (Continued)
Author/year data base studied Inclusion criteria Exclusion criteria Population at risk
reported
NEC case definition Comment on
VLBW
Incidence
(cumulative)
multicenter birth
cohort study
evaluating VLBW
infants from
multiple Level III
neonatal centers
for exposure
blood transfusion
(a risk of NEC)
incidence at 8 weeks
Bajwa et al.
2011 [23]
Swiss Neonatal
Network. Double
verification by the
Swiss Society of
Neonatology.
The data set
includes all infants
< 32 weeks of
gestation
and > 23 wks.
infants who died in
labor room
preterm less than
28 weeks of
gestation
clinical definition no comment
on the birth
weight of the
subpopulation
less than 28
weeks of
gestation
4.95%
Narang
et al. 1993
[24]
Single Neonatal
Intensive Care
Unit
All live births
during the period
January 1986 to
September 1990
Not reported VLBW infants and
pretenn infants
of gestational
age less than 32
weeks
modified Bell’s
criteria
Majority are
VLBW infants
1.5%
Lodha 2019
[25]
Tertiary neonatal
intensive care
units participating
in the Canadian
Neonatal Network
born at 22 to 28
weeks’ gestational
age
birth outside a
tertiary-level NICU,
moribund at birth,
designated as need-
ing palliative care be-
fore delivery, had
major congenital
anomalies, or lacked
cord clamping
information
22 to 28 weeks’
gestational age
According to the
modified Bell criteria,
and NEC stage 2 or
higher was classified
as medical or
surgical.
No estimate of
the
percentage of
VLBW infants
9%
Boghossian
2018 [26]
Vermont Oxford
Network center
Inborn, singleton
infants without
congenital
malformations
Infants with
unknown sex and
missing or
implausible birth
weight
Infants of
gestational ages
22 to 29 weeks
diagnosed at surgery
or postmortem or
required at least 1
clinical sign (eg,
bilious gastric
aspirate, abdominal
distension, or occult
blood in stool) and
at least 1
radiographic finding
(eg, pneumatosis
intestinalis,
hepatobiliary gas, or
pneumoperitoneum).
the mean birth
weight and SD
of the each
weeks
reported.
9%
Persson
2018 [27]
7 national
networks in high-
income countries
that are part of
the International
Neonatal Network
for Evaluating
Outcomes in
Neonates
All singleton
infants born alive
in high-income
countries who
were very preterm
(24-31 weeks’ ges-
tation) and with a
birth weight of
less than 1500 g
Multiple pregnancies
and major congenital
malformations
Very Preterm and
Very Low-Birth-
Weight Infants
Necrotizing
enterocolitis was
analyzed in a
subgroup of the
cohort because data
from the UKNC were
not available for
stage 2 or 3 NEC
Very Preterm
and Very Low-
Birth-Weight
Infants
3%
Suzuki 2018
[28]
Neonatal
Research Network
Extremly preterm
infants born
between 2008 and
2012
Infants who died
within 6 days, infants
with congenital
anomalies, whose
sex was
undetermined, or
whose records were
missing data
extremely
preterm infants
NEC was defined as
stage II/III cases,
according to the
classifications of Bell
All are VLBW
with extremly
preterm
4%
Boghossian 852 US centers Infants born Multiples and infants Large for NEC was diagnosed Mean and SD 7%
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and data from the general population was extracted to
compute the incidence (Table 2).
Qualitative review
Andersone et al. reviewed a cohort data from the Cali-
fornia Office Statewide Health Planning And Develop-
ment [OS HPD] [39]. Upon retrograde calculation of the
number of NEC cases and dividing them by a total num-
ber of NICU preterm babies the incidence of NEC was
9.1%. Whilst, Patole et al. conducted a retrospective co-
hort study reviewing 1755 neonates who were less than
34 weeks of gestation [21]. The aim was to study the ef-
fect on the incidence of NEC. In the control group (prior
to the initiation of probiotic), there were 835 babies.
Among those 250 were preterm with gestational age less
than 28 weeks. Stage II or above NEC was found in 16
cases (6% of preterm controls).
Stoll et al. [38] analyzed data on 9575 newborns with
very low birthweight and extremely low gestational age.
The incidence in this population was 11%. Llanos et al.
[3] reported the incidence among VLBW infants there-
fore was 3.29%. They used a retrospectively conducted a
population-based survey from six counties in New York
State. Holeman et al. analyzed the hospital discharge
data from the Kid’s Inpatient Database from the year
2000 [47]. Among those born with weight less than
1500 g, the number of cases was 2554 and the rate was
4342.8 per 100,000 live births annually with an incidence
of 4.3%. Fanaroff et al. evaluated VLBW infants and
compared three periods of time: 1987–1988, 1993–1994,
and 1999–2000 [20]. The analysis aimed to compare the
outcome across the time periods. They showed that the
incidence of NEC did not change over time.
Bajwa et al. reviewed the data from the Swiss neonatal
network that conatins comprehensive population-based
data of all infants in Switzerland [23]. The analysis in-
cluded 368,055 infants born between 2000 and 2004,
Ahle et al. collected data from the Swedish National
Board of Health and Welfare, the National Patient Regis-
ter, the Swedish Medical Birth Register and The Na-
tional Cause of Death Register between 1987 and 2009
[12]. The incidence of NEC in less than 750 g, 750–999
g, 1000–1499 g and 1500–2499 g were 5.31, 4.16, 1.52,
and 0.007%, respectively.
Verstrate et al. based on a retrospective cohort of 5134
neonatal intensive care unit admissions from a single
hospital Belgium found 973 cases were born with a very
low birthweight of less than 1500 g [42]. The incidence
of NEC with stage II or above, in this subgroup was
16.23%. Härkin et al. reviewed the data from the national
Registry of preterm infants born between 2005 and 2013
in Finland [43]. The incidence of NEC among preterm
babies was therefore 16.58%. Wójkowska-Mach et al.
reviewed the Polish Neonatal Surveillance Network for
Table 1 Characteristics of the included studies (Continued)
Author/year data base studied Inclusion criteria Exclusion criteria Population at risk
reported
NEC case definition Comment on
VLBW
Incidence
(cumulative)
2018 [29] participating in
the Vermont
Oxford Network
between 154 days
(22 weeks and 0
days) and 209
days (29 weeks
and 6 days) of
gestation
born with congenital
malformations
Gestational Age
Infants
at surgery or
postmortem or
required at least 1
clinical sign (eg,
bilious gastric
aspirate, abdominal
distension, occult
blood in stool) and
at least 1
radiographic finding
(eg, pneumatosis
intestinalis,
hepatobiliary gas, or
pneumoperitoneum)
birth weights
reported
Beltempo
2018
Canadian
Neonatal Network
Infants born from
22 to 28 weeks’
GA and admitted
to 30 Level 3
neonatal intensive
care units (NICUs)
Infants moribund on
admission or where
palliative care was
provided at birth due
to imminent
mortality, infants
with major
congenital
anomalies, and
infants with missing
SNAP-II
Extremely
preterm infants
NEC is defined as
stage ≥2 according
to Bell’s criteria
Mean and SD
birth weights
of both cohort
is reported
8%
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Table 2 Summary of the 27 studies included in the quantitative analysis
Period Author/Year Location Population at risk Cases of NEC in population at
risk
Population at
risk
Incidence
2003–2007 Stoll et al. 2010 [18] US VLBW infants not reported a 9575 11.0%
1991–1998 Llanos et al. 2002 [3] US VLBW infants 47 1425 3.29%
86/87, 92/93, and 98/
99
Luig et al. 2005 [4] Australia Extremely premature 127 1655 7.67%
2000 Holman et al. 2006 [19] US- 27
states
VLBW infants 2554 58,810 4.34%
201–2014 Youn 2015 [16] Korea VLBW infants 149 2326 6.41%
2011 Qian et al. 2017 China VLBW infants 221 8727 2.53%
1987–2009 Ahle et al. 2013 [12] Sweden VLBW infants 473 17,608 2.68%
2009 Wojkowska-Mach et al.
2014
Poland VLBW infants 79 910 8.68%
2007 Boo et al. 2012 [14] Malaysia VLBW infants 222 3601 6.20%
1998–2004 Wong et al. 2013 Australia VLBW infants 199 2549 7.81%
87/88, 93/94,99/2000 Fanaroff 2003 [20] US VLBW infants 786 12,628 6.23%
2004–2006 Chedid et al. 2008 UAE VLBW infants 10 173 5.78%
2000–20,209 Agrawel et al. 2015 Singapore VLBW infants 50 835 6.98%
2008–2010 Patole et al. 2016 [21] Australia Extremely premature 16 250 6.40%
2002–2011 Verstreate et al. 2016 Belgium VLBW infants 158 973 16.23%
2005–2013 Harkin et al. 2017 Finland Extremely premature 170 1025 6.58%
2007–2012 Andersen et al. 2018 US-
California
Extremely premature 1360 14,941 9.10%
2007–2010 Suciu et al. 2017 [22] Romania Extremely premature 82 480 17.08%
2010–2014 Patel et al. 2016 US-Atlanta VLBW infants 44 598 7.34%
2000–2004 Bajwa et al. 2011 [23] Switzerland Extremely premature 64 1283 4.95%
1986–1990 Narang et al. 1993 [24] India VLBW infants
2011–2015 Lodha 2019 [25] Canada Extremely premature 412 4680 9%
2006–2016 Boghossian 2018 [26] United
States
VLBW and Extremely
premature
18,129 194,736 9%
2007–2015 Persson 2018 [27] Sweden Extremely premature 2077 76,360 3%
2008–2012 Suzuki 2018 [28] Japan Extremely premature 296 8245 4%
2006–2014 Boghossian 2018 [29] USA Extremely premature 10,376 138,869 7%
2010–2015 Beltempo 2018 Canada Extremely premature 778 9230 8%
a The number of NEC cases was calculated from the incidence and the baseline population for this study
Fig. 1 The 10 criteria used to assess the risk of bias in each included studies
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all VLBW infants recorded in the national registry. They
used clinical criteria for the definition of NEC and 79 of
910 babies developed NEC [13].
Suciu et al. reviewed data from three tertiary centers
in Romania. The study included 480 preterm babies
born before 28 weeks of gestation [22]. The incidence
was estimated to be 16.6%. The Bell’s criteria were used
to define cauterizing enterocolitis as stage II and above
in this study. Agarwal et al. collected data from the sin-
gle largest neonatal center in Singapore with a vitality
threshold defined at 25 weeks of gestation [45]. The
database included all neonates who are with VLBW and
gestational age less than 29 weeks. Bell’s classification
was used to define NEC. 50 babies among 835 developed
NEC.
Qian et al. reported data extracted retrospectively from
95 major referral centers and hospitals in china covering
a large area of 29 provinces [44]. VLBW infants were
specified and the incidence of NEC according to Bell’s
criteria was presented in 2011. The data included 46,686
infants of whom, 8727 were born with VLBW. The
incidence of confirmed NEC in VLBW infants was 6.5
among a cohort of 8727 infants.
Youn et al. reported a large cohort from South Korea.
Among a total of 2326 infant with VLBW, 145 (6.8%)
were diagnosed with confirmed NEC stage II of above
[16]. Boo et al. collected data retrospectively from 31
neonatal intensive care units around Malaysia on NEC
defined by Bell’s criteria among VLBW infants. Among
the 3601 babies included, 222 developed NEC. Of these
197 had NEC II and 25 were NEC III or above according
to Bell’s staging criteria. The incidence was 6.2% [14].
Luig et al. reported data on all infants born between 24
to 28 weeks of gestation in New South Wales and Eng-
land, over three different time periods: 1986–1987,
1992–1993, and 1998–1999 [4]. The population included
1655 cases from the three groups divided to 360, 622,
and 673 cases in time periods 1986–1987, 1992–1993,
and 1998–1999 respectively. Over the entire population
the incidence was 7.67%.
Wong et al. conducted a retrospective cohort study
reviewing 2549 neonates from 10 neonatal intensive care
Fig. 2 Flow chart depicting the studies screened, selected and included based on PRISMA
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units serving New South Wales in Australia [46]. This
study population accounted for all preterm infants in the
region of Australia between 1998 and 2004. The con-
ducted the analysis complaining those exposed to ste-
roids and those who were not. The incidence of NEC
was 7.8% as 199 cases developed necrotizing enterocoli-
tis among 2549 preterm babies born before 29 weeks of
gestation.
Narang et al. 1993, collected 2200 admissions to the
NICU during the period January 1986to September 1990
[24]. Among them 33 developed NEC (Bell’s stage ≥2).
The incidence was 1.5%. Chedid et al. reviewed 173
newborns from 1 Tertiary Referral Center in UAE, Al
Ain. All the cohort were born with weight less than
1500 g [very low birthweight infants] [7]. NEC was diag-
nosed clinically. Among the study population, 10 babies
developed confirmed NEC. The incidence of NEC was
5.8%.
Lodha et al. 2019, compared neonatal outcomes after
deferred cord clamping and immediate cord clamping in
extremely low-gestational-age neonates from tertiary
neonatal intensive care units participating in theesti-
mated incidence based on Canadian Neonatal Network
in 2019 was 9% (43)9%.
Fig. 3 Risk of bias plot that shows the methodological quality assessment of the 27 studies included
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Boghossaan et al. 2018, examined infants of gestational
ages 22 to 29 weeks born between January 2006 and De-
cember 2016 at a Vermont Oxford Network center in
the United States were. NEC developed in 18,129 among
the 194,736 infants. The incidence of NEC was 9% [26].
Persson et al. 2018, conducted a retrospective cohort
study at 7 national networks in high-income countries
that are part of the International Neonatal Network for
Evaluating Outcomes in Neonates and used prospect-
ively collected data on 76,360 very preterm, singleton in-
fants. 2077 infants developed NEC and the incidence
was 3% [27].
Suzuki et al. 2018, retrospectively examined 8245 ex-
tremely preterm infants born between 2008 and 2012
using Neonatal Research Network database in Japan.
They estimated incidence to be 4% [28]. Boghossian
et al. 2018, collected 138,869 large for gestational age in-
fant’s data from 852 US centers participating in the Ver-
mont Oxford Network. The incidence of NEC was 7%
(10,376 new cases) [29]. Beltempo et al. 2018, collected
data about extremely preterm infants born from 22 to
28 weeks’ gestational age Canadian Neonatal Network.
Study population was 9230 among them 778 developed
NEC. The incidence of NEC was 8% [48].
Assessment of risk of Bias
The quality assessment of 27 individual studies carried
out as per Hoy et al. [30] criteria are summarized graph-
ically presented in Fig. 3. Studies performed very highly
on components like use of consistent mode of data col-
lection from all infants as well as sufficient follow up
time required for the desired outcome to occur. How-
ever, only about 50% of the studies had a random selec-
tion of samples. Overall, most studies scored high and
17 out of 27 studies had a lower risk of bias based on a
cut of 8/10 or more as suggested by the Hoy’s criteria.
Quantitative analysis of incidence
There were significant heterogeneity between studies, as
indicated by I2 value of 100% and the Cochrane Q- sta-
tistics (value =7473; P < 0.0001). As such we used REM
as the main model to obtain our conclusions. REM esti-
mate were 7.0% (95% CI: 6.0–8.0%) (Fig. 4), and add-
itional quality adjusted QEM provided a sensitivity
estimate of 6.0% (95% CI: 4.0–9.0%) (Fig. 5).
Publication bias
Hunter’s modified funnel Plot [36] as appropriate for the
incidence data used to evaluate the publication bias
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appear to not to show a serious concern (Fig. 6). Further,
the Eggers regression confirmed that publication bias
was not statistically significant (two tailed p-value =
0.80). The Kendall’s Tau test statistics was also not sta-
tistically indicating less likely that these studies encoun-
tered publication bias (two tailed p-value = 0.936).
Subgroup analysis
There was no significant regional variation between
North America, Western Europe and Australia as well as
Asia (Table 3). There appear to be some variation be-
tween HIC and LMIC countries, although these differ-
ences were not statistically significant. No significant
variation between VLBW infants and extreme prematur-
ity was found.
Meta-regression
There was a statistically significant increase in the log
event rate over time, quantified by the publication year
(Fig. 7).
Discussion
This study is perhaps the first attempt to provide a
pooled estimate of the incidence of Necrotizing
Enterocolitis in VLBW infants. Seven out of 100 of all
VLBW infants in NICU are likely to develop NEC as per
our synthesis. However, there were considerable hetero-
geneity in the estimates across studies. Such important
variability may be driven by myriad of factors including
the variation in the quality of health care systems.
Subgroup analysis based on geographic regions did not
reveal any differences (i.e. South East Asia versus Eur-
ope, North America and Australia). However, when
countries reporting the data on NEC were re-classified
based on income levels using Word Bank classifications
the incidence in high income counties (HIC) varied from
the low and mid income countries (LMIC), although,
these differences were not statistically significant. Such
variation may be attributed to the fewer published stud-
ies from LMIC and potential under power to detect any
differences. However, it is also possible that slightly
lower incidence reported in LMIC may be due to higher
gestational age cutoff point for resuscitation used in case
of extreme prematurity. It is also possible that the sicker
babies in LMIC may have had higher risk of mortality.
As a result the population of neonates in LMIC may ap-
pear healthier and at lesser risk of developing NEC.
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The increase in the incidence of NEC over time
that our study found using meta-regression maybe
attributed to multiple factors. Improvement in neo-
natal care and better survival of premature infants
are possible causes as well as improvement in diag-
nosis and reporting. Increase in incidence of NEC
over time can also be attributed to lack of wide scale
prevention strategies. Ahle et al. demonstrated a j-
shaped distribution of incidence over time in
Sweden. While the incidence was 150 per 10,000 live
births among VLBW infants in the late 80s, it in-
creased to approximately 800 per 10,000 live births
in VLBW, a multiple fold increase in later decade
[12]. This increase may be related to variations in
local health services. However, findings from the
analysis of the NICHD data base from the United
States reported [20] showed a different picture. They
reviewed VLBW infants from three epochs: 1987–
1988, 1993–1994, and 1999–2000. Their analysis
compared the incidence across these three periods
and they demonstrated that the incidence of NEC
did not change over time. The data presented in our
analysis represents a wider time period and a set of
more diverse healthcare settings. Due to paucity of
data available from lower income countries, the
pooled estimate may have limited external validity
and not fully generalizable to all global settings and
populations.
Our findings, however, should be understood in
the light of some limitations that this study encoun-
tered. Only 12 out 26 studies could be considered to
be of higher quality and this may be linked to the
substantially heterogeneity that we encountered. Al-
though, we employed quality effect models to adjust
for variation in study qualities, substantial heterogen-
eity noted in this study does pose a threat to evi-
dence synthesis. The diagnosis of NEC using Bell’s
criteria or similar definitions schemes is a day to day
clinical challenge. To a certain extent, two clinicians
may justifiably disagree on labeling a baby as con-
firmed NEC versus suspected NEC.
Fig. 6 Hunter’s plot used to assess the publication bias
Table 3 Subgroup analysis by region and income
Region Pooled Incidence
(%)
95% CI
All 6.0 [4.0, 9.0]
North America, Western Europe and
Australia
4.3 [2.5, 6.6]
Asia 3.9 [1.4, 7.3]
Income
All 6.0 [4.0, 9.0]
High income countries (HIC) 7.0 [4.0, 10.0]
Low and middle-income countries
(LMIC)
3.0 [1.0, 6.0]
Population at risk
All 6.0 [4.0, 9.0]
VLBW infants 6.0 [3.0, 9.0]
Extremely premature 7.0 [2.0, 13.0]
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Conclusions
Seven out of 100 infants admitted to NICU and are
VLBW are likely to develop NEC. However, there are
substantial variability in incidence reported from differ-
ent parts of the world, likely be due to differences in
clinical and health settings in addition to methodological
variations. Larger and higher quality studies on inci-
dence of NEC and associated factors, particularly form
low and middle income countries are warranted.
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